PM Toothache Maximum Strength
Natural health product licensed in Canada
- Licence holder
- CRLS
- NPN or DIN-HM
- 80040537
- Status
- Inactive licence
- Licence date
- 6 March 2013
- Revision date
- Not provided
- Form
- Pâte
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Extrait de fleurs de Chamomille Recutita (Matricaria), PEG-400, Carboxyméthylcellulose de sodium, Sacharinate de sodium, Salicylate de méthyle, Pectine, Huile minérale, Gélatine, Menthol, Pétrolatum
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | Not specified | minimum: 0.1 mL ; maximum: 0.5 mL | 4 days |
Uses authorised in Canada
For temporary relief of pain due to toothache.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid contact with eyes. If this occurs, immediately flush thoroughly with water. Do not use for more than 7 days unless directed by a health care practitioner. If symptoms do not improve within seven days, irritation, pain or redness persists or worsens, or swelling, rash or fever develops, consult your dentist or other health care practitioner promptly.
- Contre-indications
Do not use if allergic to benzocaine. Hypersensitivity/allergy is known to occur. In such a case, discontinue use. If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use.
Source
Official Health Canada record, licence 80040537
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.